Table 3.
Objective evidence of cardiac structural, functional, and serological abnormalities consistent with LVDD/raised LVP.
| Parameter | Threshold |
|---|---|
| LV mass index | ≥95 g/m2 (female), ≥115 g/m2 (male) |
| Relative wall thickness | >0.42 |
| LA volume index | >34 mL/m2 (sinus rhythm) |
| E/e′ ratio at rest | >9 |
| NT-proBNP | >125 (sinus rhythm) or >365 (AF) pg/mL |
| BNP | >35 (sinus rhythm) or >105 (AF) pg/mL |
| PA systolic pressure | >35 mmHg |
| TR velocity at rest | >2.8 m/s |
LV = left ventricular; LA = left atrial; NT-proBNP = N-terminal pro-B-type natriuretic peptide; AF = atrial fibrillation; BNP = B-type natriuretic peptide; PA = pulmonary artery; TR = tricuspid regurgitation.